Who Retatrutide Is For and Who Should Avoid It Retatrutide is currently studied in adults with obesity, adults with type 2 diabetes, and adults with weight-related conditions like knee osteoarthritis, sleep apnea, and metabolic dysfunction-associated steatotic liver disease (MASLD)
While both belong to the class of incretin mimetics, they function through different biological pathways
While at Lilly, DiMarchi had helped to synthesise GLP-1 for Suad Efendic, a leading clinical diabetes researcher from Yugoslavia based at Karolinska University in Stockholm, Sweden
Rocio Pereira, MD, chief of Endocrinology at the safety-net hospital system Denver Health and an associate professor of medicine at the University of Colorado, says that many of her patients report that semaglutide helps them eat less and that it has become easier for them to eat healthy foods and avoid junk food since starting on the medication